Calyxt

Calyxt is a publicly traded plant-based synthetic biology company headquartered in Roseville, Minnesota. With 39 employees, the company is focused on developing innovative ingredients and products using its proprietary PlantSpring™ technology platform. Calyxt is listed on the Nasdaq stock exchange under the ticker symbol CLXT. Calyxt's core focus is on engineering plant-based ingredients and products designed to address sustainability concerns and supply chain complexities faced by its customers. The company aims to provide solutions that benefit both businesses and the environment. Calyxt differentiates itself through its innovative PlantSpring™ technology platform, which enables the company to precisely modify plants at the genetic level. This technology allows for the creation of novel ingredients and products with enhanced characteristics, such as improved nutritional profiles, increased yields, and reduced environmental impact. For more information about Calyxt and its products, please visit their website at www.calyxt.com.